DETECTION OF CRESCENT SAND DUNES CONTOURS IN SATELLITE IMAGES USING AN ACTIVE SHAPE MODEL WITH A CASCADE CLASSIFIER

Crescent sand dunes called barchans are the fastest moving sand dunes in the desert, causing disturbance for infrastructure and threatening human settlements. Their study is of great interest for urban planners and geologists interested in desertification (Hugenholtz et al., 2012). In order to study them at a large scale, the use of remote sensing is necessary. Indeed, barchans can be part of barchan fields which can be composed of thousands of dunes (Elbelrhiti et al.2008). Our region of interest is located in the south of Morocco, near the city of Laayoune, where barchans are stretching over a 400&thinsp;km corridor of sand dunes. We used image processing techniques based on machine learning approaches to detect both the location and the outlines of barchan dunes. The process we developed combined two main parts: The first one consists of the detection of crescent shaped dunes in satellite images using a supervised learning method and the second one is the mapping of barchans contours (windward, brink and leeward) defining their 2D pattern. For the detection, we started by image enhancement techniques using contrast adjustment by histogram equalization along with noise reduction filters. We then used a supervised learning method: We annotated the samples and trained a hierarchical cascade classifier that we tested with both Haar and LBP features (Viola et Jones, 2001; Liao et al., 2007). Then, we merged positive bounding boxes exceeding a defined overlapping ratio. The positive examples were then qualified to the second part of our approach, where the exact contours were mapped using an image processing algorithm: We trained an ASM (Active Shape Model) (Cootes et al., 1995) to recognize the contours of barchans. We started by selecting a sample with 100 barchan dunes with 30 landmarks (10 landmarks for each one of the 3 outlines). We then aligned the shapes using Procrustes analysis, before proceeding to reduce the dimensionality using PCA. Finally, we tested different descriptors for the profiles matching: HOG features were used to construct a multivariate Gaussian model, and then SURF descriptors were fed an SVM. The result was a recursive model that successfully mapped the contours of barchans dunes. We experimented with IKONOS high resolution satellite images. The use of IKONOS high resolution satellite images proved useful not only to have a good accuracy, but also allowed to map the contours of barchans sand dunes with a high precision. Overall, the execution time of the combined methods was very satisfying.</p

Quantum paramagnetism in a non-Kramers rare-earth oxide: Monoclinic Pr2Ti2O7\rm Pr_2Ti_2O_7

Little is so far known about the magnetism of the $\rm A_2B_2O_7$ monoclinic layered perovskites that replace the spin-ice supporting pyrochlore structure for $r_A/r_B>1.78$. We show that high quality monoclinic Pr$_2$Ti$_2$O$_7$ single crystals with a three-dimensional network of non-Kramers Pr$^{3+}$ ions that interact through edge-sharing super-exchange interactions, form a singlet ground state quantum paramagnet that does not undergo any magnetic phase transitions down to at least 1.8 K. The chemical phase stability, structure, and magnetic properties of the layered perovskite Pr$_2$Ti$_2$O$_7$ were investigated using x-ray diffraction, transmission electron microscopy, and magnetization measurements. Synthesis of polycrystalline samples with the nominal compositions of Pr$_2$Ti$_{2+x}$O$_7$ ($-0.16 \leq x \leq 0.16$) showed that deviations from the Pr$_2$Ti$_2$O$_7$ stoichiometry lead to secondary phases of related, structures including the perovskite phase Pr$_{2/3}$TiO$_3$ and the orthorhombic phases Pr$_4$Ti$_9$O$_{24}$ and Pr$_2$TiO$_5$. No indications of site disordering (stuffing and anti-stuffing) or vacancy defects were observed in the Pr$_2$Ti$_2$O$_7$ majority phase. A procedure for growth of high-structural-quality, stoichiometric single crystals of Pr$_2$Ti$_2$O$_7$ by the traveling solvent floating zone (TSFZ) method is reported. Thermo-magnetic measurements of single-crystalline Pr$_2$Ti$_2$O$_7$ reveal an isolated singlet ground state that we associate with the low symmetry crystal electric field environments that split the $2J+1=9$-fold degenerate spin-orbital multiplets of the four differently coordinated Pr$^{3+}$ ions into 36 isolated singlets resulting in an anisotropic temperature independent van-Vleck susceptibility at low $T$. A small isotropic Curie term is associated with 0.96(2)\% non-interacting Pr$^{4+}$ impurities.Comment: 18 pages, 7 figures, 6 table

Useful techniques for the resection of foot melanomas

No abstract.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/34522/1/11_ftp.pd

Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019 a systematic analysis for the global burden of disease study 2019

IMPORTANCE The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. OBJECTIVE To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. EVIDENCE REVIEW The GBD 2019 estimation methods were used to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs) in 2019 and over the past decade. Estimates are also provided by quintiles of the SDI, a composite measure of educational attainment, income per capita, and total fertility rate for those younger than 25 years. Estimates include 95% uncertainty intervals (UIs). FINDINGS In 2019, there were an estimated 23.6 million (95% UI, 22.2-24.9 million) new cancer cases (17.2 million when excluding nonmelanoma skin cancer) and 10.0 million (95% UI, 9.36-10.6 million) cancer deaths globally, with an estimated 250 million (235-264 million) DALYs due to cancer. Since 2010, these represented a 26.3% (95% UI, 20.3%-32.3%) increase in new cases, a 20.9% (95% UI, 14.2%-27.6%) increase in deaths, and a 16.0% (95% UI, 9.3%-22.8%) increase in DALYs. Among 22 groups of diseases and injuries in the GBD 2019 study, cancer was second only to cardiovascular diseases for the number of deaths, years of life lost, and DALYs globally in 2019. Cancer burden differed across SDI quintiles. The proportion of years lived with disability that contributed to DALYs increased with SDI, ranging from 1.4% (1.1%-1.8%) in the low SDI quintile to 5.7% (4.2%-7.1%) in the high SDI quintile. While the high SDI quintile had the highest number of new cases in 2019, the middle SDI quintile had the highest number of cancer deaths and DALYs. From 2010 to 2019, the largest percentage increase in the numbers of cases and deaths occurred in the low and low-middle SDI quintiles. CONCLUSIONS AND RELEVANCE The results of this systematic analysis suggest that the global burden of cancer is substantial and growing, with burden differing by SDI. These results provide comprehensive and comparable estimates that can potentially inform efforts toward equitable cancer control around the world. © 2022 American Medical Association. All rights reserved. **Please note that there are multiple authors for this article therefore only the name of the first 30 including Federation University Australia affiliate “Muhammad Aziz Rahman" is provided in this record*

Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019 : a systematic analysis for the Global Burden of Disease Study 2020, Release 1

Background: Measuring routine childhood vaccination is crucial to inform global vaccine policies and programme implementation, and to track progress towards targets set by the Global Vaccine Action Plan (GVAP) and Immunization Agenda 2030. Robust estimates of routine vaccine coverage are needed to identify past successes and persistent vulnerabilities. Drawing from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2020, Release 1, we did a systematic analysis of global, regional, and national vaccine coverage trends using a statistical framework, by vaccine and over time. Methods: For this analysis we collated 55 326 country-specific, cohort-specific, year-specific, vaccine-specific, and dose-specific observations of routine childhood vaccination coverage between 1980 and 2019. Using spatiotemporal Gaussian process regression, we produced location-specific and year-specific estimates of 11 routine childhood vaccine coverage indicators for 204 countries and territories from 1980 to 2019, adjusting for biases in country-reported data and reflecting reported stockouts and supply disruptions. We analysed global and regional trends in coverage and numbers of zero-dose children (defined as those who never received a diphtheria-tetanus-pertussis [DTP] vaccine dose), progress towards GVAP targets, and the relationship between vaccine coverage and sociodemographic development. Findings: By 2019, global coverage of third-dose DTP (DTP3; 81·6% [95% uncertainty interval 80·4–82·7]) more than doubled from levels estimated in 1980 (39·9% [37·5–42·1]), as did global coverage of the first-dose measles-containing vaccine (MCV1; from 38·5% [35·4–41·3] in 1980 to 83·6% [82·3–84·8] in 2019). Third-dose polio vaccine (Pol3) coverage also increased, from 42·6% (41·4–44·1) in 1980 to 79·8% (78·4–81·1) in 2019, and global coverage of newer vaccines increased rapidly between 2000 and 2019. The global number of zero-dose children fell by nearly 75% between 1980 and 2019, from 56·8 million (52·6–60·9) to 14·5 million (13·4–15·9). However, over the past decade, global vaccine coverage broadly plateaued; 94 countries and territories recorded decreasing DTP3 coverage since 2010. Only 11 countries and territories were estimated to have reached the national GVAP target of at least 90% coverage for all assessed vaccines in 2019. Interpretation: After achieving large gains in childhood vaccine coverage worldwide, in much of the world this progress was stalled or reversed from 2010 to 2019. These findings underscore the importance of revisiting routine immunisation strategies and programmatic approaches, recentring service delivery around equity and underserved populations. Strengthening vaccine data and monitoring systems is crucial to these pursuits, now and through to 2030, to ensure that all children have access to, and can benefit from, lifesaving vaccines

Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories : the Global Burden of Diseases Study 2019

Background: The sustainable development goals (SDGs) aim to end HIV/AIDS as a public health threat by 2030. Understanding the current state of the HIV epidemic and its change over time is essential to this effort. This study assesses the current sex-specific HIV burden in 204 countries and territories and measures progress in the control of the epidemic. Methods: To estimate age-specific and sex-specific trends in 48 of 204 countries, we extended the Estimation and Projection Package Age-Sex Model to also implement the spectrum paediatric model. We used this model in cases where age and sex specific HIV-seroprevalence surveys and antenatal care-clinic sentinel surveillance data were available. For the remaining 156 of 204 locations, we developed a cohort-incidence bias adjustment to derive incidence as a function of cause-of-death data from vital registration systems. The incidence was input to a custom Spectrum model. To assess progress, we measured the percentage change in incident cases and deaths between 2010 and 2019 (threshold >75% decline), the ratio of incident cases to number of people living with HIV (incidence-to-prevalence ratio threshold <0·03), and the ratio of incident cases to deaths (incidence-to-mortality ratio threshold <1·0). Findings: In 2019, there were 36·8 million (95% uncertainty interval [UI] 35·1–38·9) people living with HIV worldwide. There were 0·84 males (95% UI 0·78–0·91) per female living with HIV in 2019, 0·99 male infections (0·91–1·10) for every female infection, and 1·02 male deaths (0·95–1·10) per female death. Global progress in incident cases and deaths between 2010 and 2019 was driven by sub-Saharan Africa (with a 28·52% decrease in incident cases, 95% UI 19·58–35·43, and a 39·66% decrease in deaths, 36·49–42·36). Elsewhere, the incidence remained stable or increased, whereas deaths generally decreased. In 2019, the global incidence-to-prevalence ratio was 0·05 (95% UI 0·05–0·06) and the global incidence-to-mortality ratio was 1·94 (1·76–2·12). No regions met suggested thresholds for progress. Interpretation: Sub-Saharan Africa had both the highest HIV burden and the greatest progress between 1990 and 2019. The number of incident cases and deaths in males and females approached parity in 2019, although there remained more females with HIV than males with HIV. Globally, the HIV epidemic is far from the UNAIDS benchmarks on progress metrics